ILMN
Illumina Inc
NASDAQ: ILMN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$120.37
-5.16% today
Updated 2026-04-29
Market cap
$18.29B
P/E ratio
22.09
P/S ratio
4.21x
EPS (TTM)
$5.45
Dividend yield
—
52W range
$74 – $156
Volume
1.6M
Illumina Inc (ILMN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
19.60%
Operating margin
19.70%
ROE
33.40%
ROA
8.39%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $184.59M | $39.97M | 67.85% | 20.48% | 21.65% |
| 2007 | $366.80M | $-278.36M | 63.89% | -82.12% | -75.89% |
| 2008 | $573.23M | $50.48M | 64.13% | 14.04% | 8.81% |
| 2009 | $666.32M | $72.28M | 69.12% | 18.85% | 10.85% |
| 2010 | $902.74M | $124.89M | 66.63% | 23.45% | 13.83% |
| 2011 | $1.06B | $86.63M | 67.18% | 18.90% | 8.21% |
| 2012 | $1.15B | $151.25M | 67.35% | 17.48% | 13.17% |
| 2013 | $1.42B | $125.31M | 64.16% | 9.44% | 8.82% |
| 2014 | $1.86B | $353.35M | 69.72% | 27.65% | 18.98% |
| 2015 | $2.22B | $461.56M | 69.78% | 27.62% | 20.79% |
| 2016 | $2.40B | $462.65M | 69.46% | 24.47% | 19.29% |
| 2017 | $2.75B | $726.00M | 66.35% | 22.02% | 26.38% |
| 2018 | $3.33B | $826.00M | 69.01% | 26.49% | 24.78% |
| 2019 | $3.54B | $1.00B | 69.63% | 27.80% | 28.28% |
| 2020 | $3.24B | $656.00M | 68.01% | 12.13% | 20.25% |
| 2021 | $4.53B | $762.00M | 69.69% | -2.72% | 16.84% |
| 2022 | $4.58B | $-4.40B | 64.83% | -91.16% | -96.07% |
| 2023 | $4.50B | $-1.16B | 60.92% | -23.73% | -25.78% |
| 2024 | $4.37B | $-1.22B | 65.44% | -19.05% | -27.97% |
| 2025 | $4.34B | $850.00M | 66.49% | 19.92% | 19.58% |